ATP6AP2 and pancreatic adenocarcinoma: This is in contrast with previous studies, which showed that ATP6AP2 expression was positively correlated with the Ki67-labeling index6, and that systemic administration of anti-ATP6AP2 antibodies into mice bearing subcutaneous pancreatic adenocarcinoma cells significantly decreased the number of Ki67-positive cells21.